DrugPatentWatch

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: paricalcitol

Summary for Generic Name: paricalcitol

Tradenames:2
Patents:5
Applicants:2
NDAs:3
Drug Master File Entries: see list8
Suppliers: see list2
Therapeutic Class:Metabolic Bone Disease Agents

Tentative approvals for PARICALCITOL

Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE; ORAL1MCG
<disabled><disabled>CAPSULE; ORAL2MCG
<disabled><disabled>CAPSULE; ORAL4MCG

Clinical Trials for: paricalcitol

The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
Status: Completed Condition: Chronic Kidney Disease

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Status: Completed Condition: Diabetic Nephropathy; Chronic Kidney Disease

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
Status: Completed Condition: Chronic Kidney Disease; Endothelial Dysfunction; Inflammation; Hypertension

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
Status: Completed Condition: Secondary Hyperparathyroidism; Dialysis

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
Status: Completed Condition: Chronic Kidney Disease; Secondary Hyperparathyroidism; Hemodialysis

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
Status: Completed Condition: Chronic Kidney Disease on Hemodialysis; Secondary Hyperparathyroidism

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Abbvie
ZEMPLAR
paricalcitol
INJECTABLE; INJECTION020819Apr 17, 1998RXYes5,597,815*PEDY<disabled>
Abbvie
ZEMPLAR
paricalcitol
INJECTABLE; INJECTION020819Apr 17, 1998RXYes5,246,925*PED<disabled>
Abbvie
ZEMPLAR
paricalcitol
INJECTABLE; INJECTION020819Apr 17, 1998RXYes5,587,497*PEDY<disabled>
Abbvie
ZEMPLAR
paricalcitol
INJECTABLE; INJECTION020819Apr 17, 1998RXYes6,361,758*PEDY<disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639

`abc